PT - JOURNAL ARTICLE AU - Zhu, Yiwen AU - Wang, Min-Jung AU - Crawford, Katherine M. AU - Ramírez-Tapia, Juan Carlos AU - Lussier, Alexandre A. AU - Davis, Kathryn A. AU - de Leeuw, Christiaan AU - Takesian, Anne E. AU - Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium AU - Hensch, Takao K. AU - Smoller, Jordan W. AU - Dunn, Erin C. TI - Sensitive period-regulating genetic pathways and exposure to adversity shape risk for depression AID - 10.1101/2021.05.13.21257179 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.13.21257179 4099 - http://medrxiv.org/content/early/2021/05/17/2021.05.13.21257179.short 4100 - http://medrxiv.org/content/early/2021/05/17/2021.05.13.21257179.full AB - Animal and human studies have documented the existence of developmental windows (or sensitive periods) when experience can have lasting effects in shaping brain structure or function, behavior, and disease risk. Sensitive periods for depression likely arise through a complex interplay of genes and experience, though this possibility has not been explored. We examined the effect of sensitive period-regulating genetic pathways identified in preclinical animal studies, alone and in interaction with socioeconomic disadvantage, a common childhood adversity, on depression risk. Using a translational approach, we: (1) performed gene-set association analyses using summary data from a genome-wide association study of depression (n=807,553) to assess the effects of three gene sets (60 genes) shown in animal studies to regulate sensitive periods; (2) evaluated the developmental expression patterns of these sensitive period-regulating genes using data from BrainSpan (n=31), a transcriptional atlas of postmortem brain samples; and (3) tested gene-by-development interplay by analyzing the combined effect of common variants in sensitive period genes and timing of exposure to socioeconomic disadvantage within a population-based birth cohort (n=6254). The gene set regulating sensitive period opening associated with increased depression risk. Notably, six of the 15 genes in this set showed developmentally regulated gene-level expression. A genome-wide polygenic risk score-by-environment analysis showed socioeconomic disadvantage during ages 1-5 years were independently associated with depression risk, but no gene-by-development interactions were found. Genes involved in regulating sensitive periods may be implicated in depression vulnerability and differentially expressed across the life course, though larger studies are needed to identify developmental interplays.Competing Interest StatementDr. Smoller is an unpaid member of the Bipolar/Depression Research Community Advisory Panel of 23andMe, Inc., a member of the Leon Levy Foundation Neuroscience Advisory Board and received an honorarium for an internal seminar at Biogen, Inc. He is Principal Investigator of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe, Inc., for which 23andMe, Inc. provides analysis time as in-kind support but no payments. The remaining authors (including the contributing Consortium members) have nothing to disclose.Funding StatementResearch reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under Award Numbers K01MH102403 and R01MH113930 (Dr. Dunn) and K24MH094614 (Dr. Smoller). It was also supported in part by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (Dr. Dunn) and an award from the Jacobs Foundation (Drs. Dunn and Takesian). The Psychiatric Genomics Consortium (PGC) has received major funding from the US National Institute of Mental Health and the US National Institute of Drug Abuse (U01 MH109528 and U01 MH1095320). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe, Inc. This publication is the work of the authors and all authors will serve as guarantors for the contents of this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Consent for biological samples has been collected in accordance with the Human Tissue Act (2004).Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary data of the genome-wide association study referenced in the manuscript are available from the original publication. Please contact the authors for information on how to access data used for other sections of the analyses.